Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KetonX is a dietary supplement formulated to facilitate nutritional ketosis by delivering exogenous ketones and supporting a metabolic shift from glucose to fat oxidation. Developed by ForeverGreen (FGXpress) as the core component of the Ketoopia weight management program, the product contains a proprietary blend of beta-hydroxybutyrate (BHB) salts, medium-chain triglycerides (MCTs), and amino acids such as L-arginine. The primary mechanism involves the direct elevation of blood ketone levels, providing an immediate energy source that bypasses traditional glucose metabolism. Additionally, BHB acts as a signaling molecule, binding to the hydroxycarboxylic acid receptor 2 (HCAR2) to modulate lipolysis and inflammatory pathways. KetonX is marketed for weight management, improved cognitive focus, and enhanced energy levels, aiming to provide the physiological benefits of a ketogenic diet without the rigorous carbohydrate restriction typically required.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on KetonX.